Search
Hologic Inc
HOLXAdd to Watchlist
76.010USD
0.0000.00%
Market hours （ET）Quotes delayed by 15 min
16.97BMarket Cap
31.32P/E TTM
More Details of Hologic Inc Company
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
Hologic Inc Info
Ticker SymbolHOLX
Company nameHologic Inc
IPO dateMar 01, 1990
CEOMacmillan (Stephen P)
Number of employees7070
Security typeOrdinary Share
Fiscal year-endMar 01
Address250 Campus Drive
CityMARLBOROUGH
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code01752
Phone15082632900
Websitehttps://www.hologic.com/
Ticker SymbolHOLX
IPO dateMar 01, 1990
CEOMacmillan (Stephen P)
Company Executives of Hologic Inc
Name
Name/Position
Position
Shareholding
Change
Ms. Christiana Stamoulis
Ms. Christiana Stamoulis
Independent Director
Independent Director
48.66K
+6.56%
Mr. Mark Horvath
Mr. Mark Horvath
Division President, Breast and Skeletal Health Solutions
Division President, Breast and Skeletal Health Solutions
22.68K
-0.50%
Mr. Essex D. Mitchell
Mr. Essex D. Mitchell
Chief Operating Officer
Chief Operating Officer
20.34K
+0.41%
Mr. Brandon Schnittker
Mr. Brandon Schnittker
Division President, GYN Surgical Solutions
Division President, GYN Surgical Solutions
17.51K
-0.51%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
13.51K
-49.06%
Dr. Ludwig N. Hantson, Ph.D.
Dr. Ludwig N. Hantson, Ph.D.
Independent Director
Independent Director
10.59K
+30.13%
Ms. Nanaz Mohtashami
Ms. Nanaz Mohtashami
Independent Director
Independent Director
5.51K
+57.93%
Ms. Stacey D. Stewart
Ms. Stacey D. Stewart
Independent Director
Independent Director
4.92K
+64.81%
Dr. Jennifer Schneiders, Ph.D.
Dr. Jennifer Schneiders, Ph.D.
President - Diagnostic Solutions
President - Diagnostic Solutions
--
--
Mr. Martin Madaus
Mr. Martin Madaus
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Christiana Stamoulis
Ms. Christiana Stamoulis
Independent Director
Independent Director
48.66K
+6.56%
Mr. Mark Horvath
Mr. Mark Horvath
Division President, Breast and Skeletal Health Solutions
Division President, Breast and Skeletal Health Solutions
22.68K
-0.50%
Mr. Essex D. Mitchell
Mr. Essex D. Mitchell
Chief Operating Officer
Chief Operating Officer
20.34K
+0.41%
Mr. Brandon Schnittker
Mr. Brandon Schnittker
Division President, GYN Surgical Solutions
Division President, GYN Surgical Solutions
17.51K
-0.51%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
13.51K
-49.06%
Dr. Ludwig N. Hantson, Ph.D.
Dr. Ludwig N. Hantson, Ph.D.
Independent Director
Independent Director
10.59K
+30.13%
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Disposables
644.20M
61.48%
Service
211.00M
20.14%
Capital equipment, components and software
187.20M
17.87%
Other
5.40M
0.52%
By RegionUSD
Name
Revenue
Proportion
United States
773.50M
73.82%
Europe
161.60M
15.42%
Asia
56.70M
5.41%
Rest of World
56.00M
5.34%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Disposables
644.20M
61.48%
Service
211.00M
20.14%
Capital equipment, components and software
187.20M
17.87%
Other
5.40M
0.52%
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Vanguard Capital Management, LLC
6.50%
BlackRock Institutional Trust Company, N.A.
5.76%
State Street Investment Management (US)
4.42%
Vanguard Portfolio Management, LLC
4.31%
Manulife Investment Management (North America) Limited
4.23%
Other
74.78%
Shareholders
Shareholders
Proportion
Vanguard Capital Management, LLC
6.50%
BlackRock Institutional Trust Company, N.A.
5.76%
State Street Investment Management (US)
4.42%
Vanguard Portfolio Management, LLC
4.31%
Manulife Investment Management (North America) Limited
4.23%
Other
74.78%
Shareholder Types
Shareholders
Proportion
Investment Advisor
45.96%
Investment Advisor/Hedge Fund
26.73%
Hedge Fund
15.94%
Research Firm
2.51%
Bank and Trust
2.26%
Sovereign Wealth Fund
2.07%
Pension Fund
1.74%
Individual Investor
0.83%
Family Office
0.05%
Other
1.91%
Institutional Shareholding
Updated: Sun, Apr 5
Updated: Sun, Apr 5
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
1664
217.15M
97.27%
-16.84M
2025Q4
1628
217.20M
97.29%
-20.53M
2025Q3
1587
223.55M
100.44%
-14.31M
2025Q2
1594
230.47M
103.62%
-13.07M
2025Q1
1635
231.71M
103.94%
-14.47M
2024Q4
1617
238.36M
106.18%
-10.05M
2024Q3
1583
240.17M
103.42%
-3.00M
2024Q2
1580
234.77M
100.61%
-6.88M
2024Q1
1595
233.34M
99.37%
-7.61M
2023Q4
1584
235.52M
98.14%
-14.13M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
12.86M
5.76%
+424.28K
+3.41%
Dec 31, 2025
State Street Investment Management (US)
9.88M
4.42%
-101.10K
-1.01%
Dec 31, 2025
Manulife Investment Management (North America) Limited
9.44M
4.23%
-1.01M
-9.65%
Dec 31, 2025
HBK Investments, L.P.
8.40M
3.76%
+8.40M
--
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
5.93M
2.66%
-15.62M
-72.47%
Dec 31, 2025
Geode Capital Management, L.L.C.
5.92M
2.65%
+22.02K
+0.37%
Dec 31, 2025
Victory Capital Management Inc.
5.61M
2.51%
+139.87K
+2.56%
Dec 31, 2025
Fidelity Investments Canada ULC
5.17M
2.32%
+5.16M
+32653.16%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
First Trust Nasdaq Lux Digi Health Solutions ETF
4.41%
LeaderShares AlphaFactor Tactical Focused ETF
3.17%
John Hancock Fundamental All Cap Core ETF
3.15%
AltShares Event-Driven ETF
2.95%
ProShares Merger ETF
2.78%
First Trust Indxx Medical Devices ETF
2.19%
Strategas Global Policy Opportunities ETF
2.08%
State Street SPDR S&P Health Care Equipment ETF
2.02%
iShares U.S. Medical Devices ETF
1.95%
Brandes US Small-Mid Cap Value ETF
1.94%
View more
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion4.41%
LeaderShares AlphaFactor Tactical Focused ETF
Proportion3.17%
John Hancock Fundamental All Cap Core ETF
Proportion3.15%
AltShares Event-Driven ETF
Proportion2.95%
ProShares Merger ETF
Proportion2.78%
First Trust Indxx Medical Devices ETF
Proportion2.19%
Strategas Global Policy Opportunities ETF
Proportion2.08%
State Street SPDR S&P Health Care Equipment ETF
Proportion2.02%
iShares U.S. Medical Devices ETF
Proportion1.95%
Brandes US Small-Mid Cap Value ETF
Proportion1.94%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
